🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter uncontrolled study of sorafenib in patients with unresectable...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00586105
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-06
Trial ID
NCT00495872
Treatments Being Tested
Standard chemotherapy drugs generally work by killing rapidly dividing cell...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07
Trial ID
NCT00714948
Treatments Being Tested
To determine the maximum tolerated radiation dose with concurrent sorafenib...
Status
Withdrawn
Location
Froedtert Memorial Lutheran Hospital
Start Date
2012-06
Trial ID
NCT01618253
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00861419
Patients with recurrent, refractory or metastatic solid tumors have a disma...
Status
Completed
Location
Cancer Therapy and Research Center at UTHSCSA
Start Date
2012-06
Trial ID
NCT01634893
Treatments Being Tested
To assess the safety, tolerability, and pharmacokinetic profiles of AMG 479...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00974896
Treatments Being Tested
This study involves a course of radiation to up to 5 tumors in the particip...
Status
Withdrawn
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2017-03-27
Trial ID
NCT02989870
Treatments Being Tested
This study involves the use of oxaliplatin, capecitabine, and sorafenib whi...
Status
Completed
Location
University of Wisconsin
Start Date
2008-02
Trial ID
NCT00634751
Treatments Being Tested
This phase II trial is studying how well sorafenib works in treating patien...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2005-10
Trial ID
NCT00131937
Treatments Being Tested